Read More Dividends Earnings News Here’s How Much $100 Invested In Crocs 5 Years Ago Would Be Worth Today By Benzinga Insights February 21, 4:03 PM Crocs (NASDAQ:CROX) has outperformed the market over the past 5 years by 45.0% on an annualized basis producing… CROX
Read More Movers News Offerings What’s Going On With Cleveland-Cliffs Stock Today? By Adam Eckert April 11, 9:35 AM Cleveland-Cliffs Inc (NYSE: CLF) shares are trading higher Tuesday. CLF
Read More Biotech General News Paratek Announces First Milestone Towards Creating A U.S. Manufacturing Supply Chain For NUZYRA Under BARDA Project BioShield Contract By Benzinga Newsdesk October 31, 8:08 AM Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) today announces the commercial availability of U.S.-produced NUZYRA® (omadacycline) tablets. This milestone follows a successful technology transfer by Paratek and PRTK
Read More Analyst Ratings News Price Target Guggenheim Maintains Buy on Phreesia, Raises Price Target to $35 By Benzinga Newsdesk September 8, 7:40 AM Guggenheim analyst Jack Wallace maintains Phreesia (NYSE:PHR) with a Buy and raises the price target from $30 to $35. PHR